NCT01678105
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands treatment 2 completed NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) treatment 2 active_not_recruiting NCT02857712
Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 treatment 2 completed NCT05884320
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers treatment 2 recruiting NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential Needs No drug interventions health_services_research Not Available not_yet_recruiting NCT03360890
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors treatment 2 suspended NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene No drug interventions treatment 1 / 2 completed NCT02048254
Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer No drug interventions treatment 3 unknown_status NCT03729297
Cabozantinib in Advanced Salivary Gland Cancer Patients treatment 2 terminated NCT01969578
Androgen Deprivation Therapy in Advanced Salivary Gland Cancer treatment 2 active_not_recruiting NCT06091878
Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers No drug interventions Not Available Not Available not_yet_recruiting NCT01344356
Stereotactic Body Radiotherapy for Head and Neck Tumors No drug interventions treatment 4 completed NCT05008237
Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study treatment 2 unknown_status NCT04291300
Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients treatment 2 completed NCT05694819
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) treatment 2 active_not_recruiting NCT03319641
PSMA-PET Imaging for Advanced ACC/SDC No drug interventions diagnostic Not Available completed NCT03172624
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer treatment 2 active_not_recruiting NCT02401763
Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis No drug interventions Not Available Not Available unknown_status NCT04140526
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC treatment 1 / 2 recruiting NCT04209660
Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers treatment 2 recruiting NCT05390294
Survival With Patients Treated With Salivary Gland Cancer No drug interventions Not Available Not Available completed NCT05074940
Amivantamab in Adenoid Cystic Carcinoma treatment 2 recruiting NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) treatment 2 recruiting NCT01703455
Activity of Sorafenib in Salivary Gland Cancer diagnostic 2 completed NCT00509002
Iressa Study in Patients With Salivary Gland Cancer treatment 2 completed NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT04620187
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas treatment 2 recruiting NCT04214353
PSMA-PET Imaging Before and After ADT in Advanced SDC Patients No drug interventions other Not Available unknown_status NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) treatment 1 active_not_recruiting NCT02042885
A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer No drug interventions treatment 1 / 2 terminated NCT00886132
A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands treatment 2 completed NCT02012699
Integrated Cancer Repository for Cancer Research No drug interventions Not Available Not Available recruiting NCT03781986
APG-115 in Salivary Gland Cancer Trial treatment 1 / 2 active_not_recruiting NCT02069730
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes treatment Not Available active_not_recruiting NCT03924466
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients No drug interventions diagnostic 2 recruiting NCT05483374
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers No drug interventions Not Available Not Available recruiting NCT05898373
Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC treatment 1 / 2 not_yet_recruiting NCT03942380
Cell-free Tumor DNA in Head and Neck Cancer Patients No drug interventions diagnostic Not Available recruiting NCT05010629
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma treatment 2 active_not_recruiting NCT04832438
9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma treatment 2 withdrawn NCT02749903
Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers treatment 2 unknown_status NCT02091141
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors treatment 2 completed